4 бет - Ең жақсы онкологияның онкологтар - ЖОҒ-631 дәрігерлер

Профессор Риккардо Розати Италияның Милан қаласындағы Сан Раффаэле зерттеу ауруханасының гастроэнтерологиялық хирургия (GI) бөлімін басқарып отыр. Ол жалпы медицина және жалпы хирургия бойынша медициналық дәрежелерін тәмамдап, торакальдық хирургия бойынша мамандандыру алған, 30 жылдан астам тәжірибесі бар жоғары білікті хирург. Ол бірнеше хирургиялық қауымдастықтың мүшесі болып табылады және 300-ден астам жарияланымдар жазған. Оның бөлімі жылына шамамен 2,000 хирургиялық жағдайдарды емдейді.

Professional Background

• Medical Education: Licensed Medical Doctor, UNAM School of Medicine, Mexico City.
• Advanced Studies: Degrees and diplomas in Business Administration, Neuroscience, Neuroanatomy, and Aesthetic Medicine.
• Certifications and Workshops:
  • International Congress on Regenerative Medicine and Cell Therapy.
  • Congress on Regenerative and Functional Medicine.
  • Workshop on Regenerative and Functional Medicine.

Areas of Expertise

• Regenerative Medicine & Mesenchymal Stem Cell Applications.
• Neuroscience & Neuroanatomy.
• Functional and Aesthetic Medicine.

Doctor Oreste Gentilini is an Italian specialist in breast cancer treatment with over 20 years of experience, providing over 5,000 breast cancer surgeries. He is the head of the Breast Unit in San Raffaele Hospital and the SOUND study at the European Institute of Oncology of Milan. He has authored over 100 papers on breast tumors treatment, with a focus on breast cancer management in young women and pregnant patients. He is a founding member and Vice President of EU-BREAST, and a member of the board of directors of the Italian National Association of Senologists and Surgeons (ANISC).

Professional Resume

Basic education

• Electronic Engineering , Buenos Aires (1984)
• Physics of Radiotherapy , National Atomic Energy Commission of Argentina (CNEA, 1984)
• Master of Medical Physics , Universities of Toulouse and Paris (1986)
• Doctor of Science in Medical Physics , Universities of Toulouse and Paris (1990, Stereotactic Radiotherapy)

Publications

• Scientific index: 36.93
• Number of publications: 140

Professional activity

• 1980-1984 – Lecturer, University of Buenos Aires
• 1982-1984 – Academy of National Medicine of Argentina
• 1985-2018 – Institut Curie (Paris)
  • Latest positions:
    • Technical Director of the Proton Therapy Center
    • Head of the Department of Medical Physics

Research Internships as a Visiting Professor

• 2003-2004 – Massachusetts General Hospital & Harvard Medical School (Boston, USA)
• 1998 – Indiana University Cyclotron Facility (Bloomington, USA)

Membership in scientific committees

• 2014 – CERN International Strategy Committee for Medical Applications
• 2000 – Conseil Scientifique National de Hadrontherapie (France)
• 2012 – The Belgian Hadrontherapy Center Foundation
• Scientific and expert consultant for companies: IBA, IBA Dosimetry, Varian Particles, Siemens, Tomotherapy
• Scientific advisor at proton therapy centers in various countries:
  • China (Wanjie)
  • South Africa (Cape Town)
  • USA (Indiana, New York)
  • Italy (Trento)
  • South Korea (Seoul)
  • France (Caen)
  • Netherlands (Maastro)
  • Argentina (Buenos Aires)
  • Austria (MedAustron)
• Member of the Scientific Council at the Embassy of Argentina in France

Reviewing articles for scientific journals

• Physics in Medicine and Biology
• Medical Physics
• Physics Medicine
• Radiotherapy and Oncology
• Radiation Protection Dosimetry
• Radioprotection
• Cureus and others

Membership in scientific societies

• PTCOG (Particle Therapy Cooperative Group) – Chairman (2010-2013)
• ESTRO (European Society for Radiotherapy and Oncology)
• SFPM (Société Française de Physique Médicale)
• PMSF (Physiciens Médicaux Sans Frontières)

Teaching activities

• Master's program "Medical Physics" , Faculty of Medicine, University of Paris-Sud
• School of Proton Therapy ESTRO
• PTCOG Educational Master Classes
• Inter-University Diploma in High-Tech Radiotherapy
• Diploma in Radiation Biology and Radiation Protection in Radiotherapy (France)
• AAPM Summer School , Colorado Springs, USA (2015)
• Scientific supervision of postgraduate students, masters students, interns (up to 10 students per year)
• Invited lectures in various countries around the world (about 10 per year)

Grants and funding received (more than €50 million)

1. MIGAC – New Proton Therapy Centre of the Institut Curie
2. Grant Canceropole
   • (a) Targeted proton therapy for pediatric and adult tumors: technical optimization, radiobiology, socioeconomic assessment
   • (b) Dynamic proton therapy
3. Grant Physician – DEDIPRO (development of a new diamond detector and fast radiation therapy planning system for pulsed proton beams)
4. Industrial and regional grants – Areva 1-2-3, Feder, Varian, etc.
5. European Commission Grants
   • INFRAIA-02-2017 – INSPIRE (Infrastructure for International Proton Therapy Research)
6. IDEX Paris-Saclay – NanoTheRad (research on nanoparticles in medicine)

This specialist has made significant contributions to the development of proton therapy, radiation oncology and medical physics, combining scientific research, teaching and work at the world's leading medical and research institutions.

Профессор Массимо Фалькони 30 жылдан астам тәжірибесі бар ұйқы безінің ауруларына маманданған гастроинтестиналдық онколог. Ол Миландағы Оспедале Сан Раффаэле ауруханасында жұмыс істейді және 3 600-ден астам операцияларды, соның ішінде дисталды, тоталды, орта панкреатэктомияларды, ұйқы безінің резекцияларын және ядролық операцияларды жүргізген. Ол IRCCS Оспедале Сан Раффаэледегі Ұйқы безі хирургиясының және Панкреас трансляциялық және клиникалық бөлімшесінің директоры болып табылады, Жапония, Испания, Германия және Швециядағы халықаралық тәжірибесі бар. Профессор Фалькони 330-дан астам мақаланың авторы және 350-ден астам итальяндық және 220-дан астам халықаралық конференцияларға қатысқан, бірнеше ұйымдардың мүшесі болып табылады.

Zhang Yanjun, MD, is a Chief Physician and Master’s Supervisor with 30 years of experience in tumor imaging and radiation oncology. He treats both pediatric and adult patients. His focus includes primary and secondary tumors, neuro-oncology, and stereotactic radiotherapy.

He is proficient in radiotherapy for cancers of the lung, liver, nasopharynx, head and neck, esophagus, breast, rectum, cervix, and prostate, as well as lymphoma and central nervous system tumors.

He is a member of the Central Nervous System Tumor Radiotherapy Group of the Second Committee of the Radiation Oncology Physicians Branch of the Chinese Medical Doctor Association. He serves on the Executive Committee of the First Chinese Oncology Radiation Therapy Cooperation Group of the World Association of Chinese Oncology Physicians. He is also a member of the National Digestive Oncology Expert Committee of the Radiation Oncology Professional Committee of the Wu Jieping Medical Foundation. He was a visiting scholar twice at leading U.S. cancer radiotherapy centers. He has published 46 papers in core journals and international conferences.

Head of Teaching at the Puerto Vallarta Regional Hospital

2020-2023

Medical records manager at the Regional Hospital of Puerto Vallarta 2 months 2020

General practitioner in private medical office

2015-2022

Doctor in charge of weight control clinic

2013-2014

Medical assistant in dermatology clinic

2008-2013

Medical Assistant in Dermatological procedures.

 Medical Assistant in minimally invasive surgical procedures

 Operation of fractional laser machine - IPIXEL-ER and

facial rejuvenation with IPL.

 Experience in laser hair removal with Intense Pulsed Light and

radiofrequency

 Experience with ultrasonic cavitation

 Experience with ultraviolet (UV) light phototherapy machine for the

treatment of psoriasis and vitiligo.

 Experience assisting in Botox and Fillers procedures.

 Biomagnet certified by the Higher Institute of Biomagnetism

doctor ISAAC GOIZ DURAN

 Experience in clinical records

 Training in continuing education and professional development of teachers

Professor Pietro Mortini MD is a highly experienced Italian neurosurgeon who specializes in neuro- and radiosurgeries with a focus on minimally invasive spine and brain operations. He is a Visiting Professor at the George Washington University, has a degree in Otorhinolaryngology and Neurosurgery from the University of Milan and University of Verona, and has patented a method of manufacturing a device for regenerating biological tissues. He also provides research in microsurgical therapy of pituitary adenomas and radiosurgery for uveal melanoma and is a member of the Italian Society of the Cranial Base.

Personal Information 

Sex:  Male

Born : 1968 

Professional Experience

Gayrettepe Florence Nigthingale Hospital

Medical Oncology Department

Besiktas/Istanbul/Turkey (ongoing)

Education:

He became Professor (22/April /2016)

Medical Oncology

Attending Phys.in Gastrointestinal Oncology (January 2005 ,2009)

Istanbul University Oncology Institue,

Department of Medical Oncology

Medical Oncology Fellowship (December 2001-December2004)

Istanbul University, Istanbul Medical Faculty

Hemodialysis Traning (May1996-January1997)

Istanbul University ,bCerrahpasa Medical Faculty

Internal Medicine Residency (November 1991-November 1996)

Istanbul University ,bCerrahpasa Medical Faculty

Ege University Medical Faculty (1985-1991)

Professional Experience

February 1999-November 2001

Metropolitan Florence Nigthingale Hospital

American Cancer Center, Gayrettepe/İstanbul

April1997- October 1998

Bayraktar Dialysis Center

Güngören/ Istanbul

Membership

Turkish Medical Oncology Association

ENET(European Neuroendocrine Tumour Society)

ESMO

ASCO

Др. Джорджия Мангили 2002 жылдан бастап Сан Раффаэле Ғылыми Институты Ауруханасындағы Медициналық Гинекологиялық Онкология Тобының жетекшісі болып табылады. Ол жалпы медицина мамандығын, гинекология және акушерлік, онкология бойынша мамандықтарын аяқтаған және акушерлік және гинекология бойынша қауымдастырылған және профессор болып табылады. Оның жұмысы гинекологиялық онкология, сирек гинекологиялық ісіктер, онкологиядағы құнарлылықты сақтау және қатерлі ісік пен жүктілікке арналған. Ол Трофобластикалық Ауруларды Емдеу Еуропалық Ұйымының, Гинекологиялық Онкология Еуропалық Қоғамының және Италияның Гинекологиялық Онкология Қоғамының мүшесі.

Activities • Prevention, research and early diagnosis of cancer • Palliative care in cancer • Cytotoxic chemotherapy • Hormontherapy • Targeted treatment • Immunotherapy Education • 2004 -2010 - Istanbul University, Istanbul faculty of medicine • 2011-2015 - Istanbul University, Istanbul faculty of medicine, internal medicine specialist • 2013-2014 - Cleveland Clinic Endocrinology Department, research associate • 2016-2019 Bezmiâlem Foundation University Medical Oncology Subdivision • Dissertation: Prognostic value of absolute monocyte count in patients with mantle cell lymphoma. • Subdivision Dissertation: An effect of adjuvant chemotherapy on lipid profile and anthropometric parameters in patients with breast and colon cancer. Publications • Circulating Thyroid-Stimulating Hormone Receptor Messenger RNA as a Marker of Tumor Aggressiveness in Patients with Papillary Thyroid Microcarcinoma. Aliyev A, Gupta M, et al. Endocr  18. • The utility of peripheral thyrotropin receptor mRNA in the management of differentiated thyroid cancer. • Aliyev A, Soundararajan S, Bucak E et al. Surgery.  • Diagnostic accuracy of circulating thyrotropin receptor messenger RNA combined with neck ultrasonography in patients with Bethesda III-V thyroid cytology. Aliyev A, Patel J, Brainard J, et al. Surgery.2016 Jan;159(1):113-7. doi: 10.1016/j.surg.2015.06.063. Epub 2015 Oct 9. • Role of Urotensin-2 in 5-Fluorouracil-Related Arterial Vasoconstriction in Cancer Patients. Seker M, Aliyev A, et al. Oncol Res Treat. Epub 2018 Aug 20. • Pertuzumab, trastuzumab and taxane-based treatment for visceral organ metastatic, trastuzumab-naive breast cancer: real-life practice outcomes. Esin E, Oksuzoglu B, Bilici A, Aliyev A. Cancer Chemother Pharmacol.2019 Jan; Epub 2018 Oct 30. • Usefulness of serum M30 and M65 levels to predict response to neoadjuvant chemotherapy in patients with breast cancer. Turk HM, Aliyev A, Celik RS. Curr Probl Cancer.2019 Jul 29. pii: currproblcancer.2019.06.009. • Prognostic impact of primary tumor location on survival in metastatic colorectal cancer patients: A single center experience. Tarik Demir, Murat Araz, Altay Aliyev. Medicine Science International Medicine Journal. • Oral presentations 

Education/Academic Experience

Apr 1995 – Oct 2001                Medical School of Aristotle University of Thessaloniki, Greece

Mar 2007                                   IELTS Certificate (Overall Band Score 7.5)

Feb 2011                                    CCST in Urology, Aristotle University of Thessaloniki, Greece

June 2012                                  Fellow of the European Board of Urology (FEBU)

Sept 2014                                  Fellow in Andrology/Reconstructive Surgery (Mr Giulio Garaffa,         UCLH / Mid-Essex)

Apr 2016                                   Fellow of the Royal College of Surgeons of England (FRCS Eng)

Oct 2018                                   Honorary Senior Lecturer St Andrews University

Sep 2019                                   Urology ChM Tutor in Andrology and Minimally Invasive Surgery (MIMS) University of Edinburgh

Aug 2020                                  European Union Expert Panel Member of in vitro Medical Devices (EU EXPAMED)

Current and Previous appointments

Current appointment

May 2022- Present         Consultant Urologist German Oncology Centre, Limassol, Cyprus

Previous appointments

Nov16- May 2021       Consultant Urological Surgeon Victoria/ Queen Margaret Hospital Fife, Scotland.

Nov 2012 - Oct 2016      Consultant Urologist Broomfield Hospital, Mid-Essex Hospitals Trust 

Jan 2011 - Oct 2012      Urology Clinical Research Fellow, Spelialist Registrar Level), Bristol Royal Infirmary, United Bristol Hospitals Trust

Dec 2009 -Dec 2010      Urology Resident G. Gennimatas Hospital, Aristotle University of Thessaloniki

Duties

• Performing routine and major Penile / Urethral Reconstruction as well as Core Urology procedures twice weekly at Victoria and Queen Margaret Hospitals (Green light prostatectomy, Urolift Service lead, Prostate template biopsies, General urology)

Consultant Urologist providing and supervising the services of andrology and urethral reconstruction surgery. Also covering a general urology one stop outpatient clinics three times per week (Victoria and Queen Margaret Hospitals).

Participation in once weekly local cancer and once monthly specialist male uro-genital reconstruction MDT meetings (Honorary contract at the Western General Hospital, Edinburgh) as well as grand ward rounds.

Undergraduate student trainer and member of examiners panel at St Andrews University, Scotland.

Participation in 1:9 on call Urology Consultant rota.

Research

• Victoria Hospital, Kirkcaldy (NHS Fife) lead investigator. A prospective, multicentre study with subgroup randomisation into MRI-U/S image fusion guided prostate biopsies and routine transrectal U/S guided biopsies.  (MULTIPROS Study)
•  
• Broomfield Hospital (MEHT) sub-investigator. A pragmatic multicentre randomised superiority trial of open urethroplasty versus endoscopic urethrotomy. (OPEN Study)
•  
• Broomfield Hospital (MEHT) sub-investigator. A Multicentre randomised controlled trial of extracorporeal shockwave lithotripsy, as first treatment option, compared with direct progression to ureteroscopic treatment, for ureteric stones. (TISU
• Study)
•  
• Bristol Royal Infirmary sub-investigator. A Multicentre Randomised Controlled Trial of the Use of Drug Therapy in the Management of Symptomatic Ureteric Stones in Hospitalised Patients. (SUSPEND Study)
•  
• Bristol Royal Infirmary sub-investigator. A Multicentre Prospective Single Arm Intervention Trial Evaluating Focal Therapy using High Intensity Focused Ultrasound (Sonablate 500) for Localised Prostate Cancer. (HIFU INDEX Study)
•  
• Bristol Royal Infirmary sub-investigator, A Randomised Controlled Trial to Determine the Effect of Decapeptyl on Reduction of Prostate Volume Pre-Radiotherapy Compared with Standard Therapy (Zoladex). (EDVART Study)

Teaching Experience

Fife Simulation BPH Course Fascilitator (Scottish Urology Training Programme, Queen Margaret Hospital, Dumfermline Fife)

Urology Simulation boot camp Faculty member (St James's University Hospital, Leeds)

General Practitioner Urology Training Programme Fascilitator (ScotGem)

Objective Structured Clinical Examination (OSCE) assessor (St Andrews University Medical School)

Teaching (case-based discussions) and trainee supervision in theatres (East Anglia / East of   Scotland Deaneries trainees)

FY1 Doctors Urology teaching Bristol Royal Infirmary (University Bristol Hospitals Trust)

Undergraduate teaching of medical students in General Hospital of the city of Drama, Greece

Anatomy, Physiology and First Aid to Undergraduate nursing students

Professor, Head of the Department of Obstetrics and Gynecology. Oncogynecologist.

Dr. Auala Hubert is a board-certified medical oncologist and radiotherapist with 33 years of clinical experience. She works at Hadassah Medical Center and speaks both English and Hebrew. Dr. Hubert leads the Gastrointestinal Cancer Center. She is also a senior physician in the Oncology Department.

She earned her M.D. from Hadassah University Hospital. She holds board certifications in oncology and radiotherapy. Dr. Hubert has passed USMLE Parts I and II. She is a member of the Israel Society of Clinical Oncology, Israel Medical Society, and Israel Cancer Association. Dr. Hubert also serves on several medical and social service committees, where she helps advance cancer care.

Dr. Yahya Özel is a highly experienced general surgeon with expertise in bariatric surgery, hepatobiliary diseases, abdominal hernias, endocrine surgery, and oncological surgery. He completed his medical education at Istanbul University, Istanbul Faculty of Medicine in 1990 and pursued his specialization in General Surgery at Haydarpaşa Numune Training and Research Hospital between 2001 and 2006. His commitment to advanced surgical techniques led him to further training at Tokyo University Hospital, Japan, in the Hepato-Biliary-Pancreatic Surgery and Artificial Organ Division under renowned experts M. Makuuchi and N. Kokudo.

Throughout his career, Dr. Özel has worked at prestigious institutions, including Istanbul University Faculty of Medicine, Haydarpaşa Numune Training and Research Hospital, and Ümraniye Training and Research Hospital. His extensive experience includes roles in ERCP and surgical endoscopy, as well as advanced laparoscopic and robotic surgery. In addition to his clinical practice, he has served as an academic faculty member at Doğuş University, contributing to the education and training of future medical professionals.

Dr. Özel holds several certifications in surgical endoscopy, including the Turkish Surgical Proficiency Certificate. His dedication to minimally invasive surgical techniques, obesity treatment, and hepatobiliary surgery has made him a sought-after specialist in his field. With a career spanning over three decades, he continues to provide high-quality, patient-centered surgical care, ensuring the best outcomes through his expertise and innovative approach.

Prof. Montorsi is one of the top Italian experts in Urology and Andrology, with numerous scientific awards and 8,000+ urology/andrology surgeries. He directs the Urological Research Institute (URI) in Italy, is recognized among the most influential researchers of the past decade, and has developed his vein patching method to correct occlusive vein dysfunction. He is an Honorary Fellow of the Royal College of Surgeons of England and has written over 1,000 papers. He is a member of various medical organizations.

Personal information

Title: Professor Doctor

Branch: Radiation Oncology

Work History:

1 GATA Military Medical Faculty

2 Gayrettepe Florence Nightingale Hospital

3 T.R. Demiroğlu Bilim University \ Associate Professor

4 T.R Demiroğlu Bilim University \ Professor

Medical Specialties and Subspecialties:

1 Head and Neck Cancers

2 Radiation Oncology

Priority treatments:

1 Prostate cancer

2 Conformal treatments

Special advanced health technologies:

1 Truebeam Stx Technology

2 Halcyons

Education

1991 - Istanbul University Istanbul Faculty of Medicine

1996 - Istanbul University Cerrahpaşa Faculty of Medicine Radiation

Oncology Specialization Training

Experience

2022 PRIVATE MEDIPOL BAHÇELİEVLER HOSPITAL

2021 - 2021 Prof. Dr. Cemil Taşçıoğlu City Hospital, Medical Oncology Clinic Education Officer

2021 - 2021 Prof. Dr. Cemil Taşçıoğlu City Hospital

2020 - 2021 Yüzüncü Yıl University Faculty of Medicine

2020 - 2021 Head of the Department of Medical Oncology, Yüzüncü Yıl University Faculty of Medicine, Assoc. Dr.  

2018 - 2021 Lecturer - Yüzüncü Yıl University Faculty of Medicine, Head of Medical Oncology Department  

2018 - 2021 Yüzüncü Yıl University Faculty of Medicine

2015 - 2018 University of Health Sciences, Okmeydanı Training and Research Hospital

2015 - 2018 University of Health Sciences, Okmeydanı Training and Research Hospital, Medical Oncology Clinic, Sub-branch assistant

2012 - 2015 Kanuni Sultan Süleyman Training and Research Hospital, Internal Medicine specialist

2012 - 2015 Suleiman the Magnificent Training and Research Hospital,

2008 - 2012 Haseki Training and Research Hospital

2006 - 2008 Kızıltepe No. 3 Health Center General Practitioner.

Education

2018

İstanbul Okmeydanı Eğitim ve Araştırma Hastanesi, Tıbbı Onkoloji

2018

İstanbul Okmeydanı Eğitim ve Araştırma Hastanesi, Tıbbı Onkoloji, İstanbul Okmeydanı Eğitim ve Araştırma Hastanesi, Tıbbı Onkoloji

2012

İstanbul Haseki Eğitim ve Araştırma Hastanesi, İç Hastalıkları, İstanbul Haseki Eğitim ve Araştırma Hastanesi, İç Hastalıkları

2012

İstanbul Haseki Eğitim ve Araştırma Hastanesi, İç Hastalıkları

2007

Uludağ Üniversitesi Tıip Fakültesi, Tıip Fakültesi, Uludağ Üniversitesi Tıip Fakültesi, Tıip Fakültesi

Dr. Antonio Alcaraz is a Spanish uro-oncologist and transplantologist with over 30 years of experience and 500 successful operations, specializing in the treatment of prostate cancer, kidney, bladder, and other urogenital system pathologies using minimally invasive and robotic systems, as well as congenital pathologies in children. He is a member of several prestigious urological societies.